Company news

Share this article:

Mylan announced that it has completed its acquisition of Merck KGaA's generics business. Mylan and Merck KGaA initially announced the signing of a definitive agreement under which Mylan would acquire Merck Generics for $6.8 billion in an all-cash transaction on May 12.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions